Moderna receives full approval for COVID-19 vaccine by U.S. FDA
The U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age and older in the U.S.
Breaking news
Egyptian prime minister cabinet grants the golden license to “Gennvax Egypt”
Egyptian prime minister cabinet grants the golden license to “Gennvax Egypt” to establish and operate the largest scientific and regional R&D center and a facility
July 20, 2023
